Concepedia

Michael Mish

MM

Statistics

Publications

14

Citations

569

H-Index

12

Active since

1997

Affiliations

Gilead Sciences (United States)(Current)

Michael Mish is an author at Gilead Sciences (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1997–2020

14

Publications

14

Asymmetric Dipolar Cycloadditions of Me<sub>3</sub>SiCHN<sub>2</sub>. Synthesis of a Novel Class of Amino Acids:  Azaprolines

Michael Mish, Francisco M. Guerra, Erick M. Carreira · Journal of the American Chemical Society · 1997 · 88 citations

, , +12

Versatile, Diastereoselective Additions of Silyl Ketene Acetals, Allyl Tributylstannane, and Me<sub>3</sub>SiCN to <i>N</i>-Acyl Pyrazolines:  Asymmetric Synthesis of Densely Functionalized Pyrazolidines

Francisco M. Guerra, Michael Mish, Erick M. Carreira · Organic Letters · 2000 · 81 citations

, , +14

Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle

Richard L. Mackman, Victoria A. Steadman, David K. Dean et al. · Journal of Medicinal Chemistry · 2018 · 78 citations · Full text

, , +17

Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B

Richard L. Mackman, Michael Mish, Gregory Chin et al. · Journal of Medicinal Chemistry · 2020 · 77 citations · Full text

, , +14

Toll‐Like Receptor 8 Agonist GS‐9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B

Stéphane Daffis, Scott Balsitis, Jason Chamberlain et al. · Hepatology · 2020 · 72 citations · Full text

, , +15

1–5 of 14